Antimicrobial peptides CS-piscidin-induced cell death involves activation of RIPK1/PARP, and modification with myristic acid enhances its stability and tumor-targeting capability
暂无分享,去创建一个
Xiaowan Ma | Hui Luo | Ying Qiao | Qingyu Zhang | Ning Li | Xingmei Jiang | Xiaoju Qiu | HuangHuang Chang
[1] O. Bakare,et al. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer , 2021, Biomolecules.
[2] M. Wangpaichitr,et al. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration , 2021, International journal of molecular sciences.
[3] Lin Hu,et al. Myristoylation-mediated phase separation of EZH2 compartmentalizes STAT3 to promote lung cancer growth. , 2021, Cancer letters.
[4] Zhengshuang Xu,et al. Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool , 2021, Marine drugs.
[5] Haisheng Peng,et al. Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism , 2021, Journal of drug targeting.
[6] Shixia Bu,et al. Efficient iron utilization compensates for loss of extracellular matrix of ovarian cancer spheroids. , 2021, Free radical biology & medicine.
[7] Xiaowan Ma,et al. Cerocin, a novel piscidin-like antimicrobial peptide from black seabass, Centropristis striata. , 2020, Fish & shellfish immunology.
[8] L. Kuroki,et al. Treatment of epithelial ovarian cancer , 2020, BMJ.
[9] W. Zhou,et al. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation , 2020, Oncogene.
[10] Shuaibing Shi,et al. N-terminal Myristoylation Enhanced the Antimicrobial Activity of Antimicrobial Peptide PMAP-36PW , 2020, Frontiers in Cellular and Infection Microbiology.
[11] N. Hacker,et al. The untapped potential of ascites in ovarian cancer research and treatment , 2020, British Journal of Cancer.
[12] T. Meinnel,et al. Myristoylation, an Ancient Protein Modification Mirroring Eukaryogenesis and Evolution. , 2020, Trends in biochemical sciences.
[13] W. El-Deiry,et al. Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.
[14] M. Akrami,et al. Recent progress in biomedical applications of RGD-Based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review. , 2019, Journal of biomedical materials research. Part A.
[15] M. D'Arcy. Cell death: a review of the major forms of apoptosis, necrosis and autophagy , 2019, Cell biology international.
[16] Zhepeng Liu,et al. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. , 2019, International journal of pharmaceutics.
[17] Yuanhui Ji,et al. RGD‐modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] A. Letai,et al. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.
[19] In-geun Ryoo,et al. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling , 2018, Cell Death & Disease.
[20] D. Sharma,et al. Necroptosis: a regulated inflammatory mode of cell death , 2018, Journal of Neuroinflammation.
[21] D. Armstrong. New Therapies for Ovarian Cancer. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[22] R. Borojevic,et al. Characterization of Gastrospheres Using 3D Coculture System. , 2018, Methods in molecular biology.
[23] A. Toplak,et al. Enzyme-catalyzed peptide cyclization. , 2017, Drug discovery today. Technologies.
[24] D. Xing,et al. RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers. , 2017, Biomaterials.
[25] P. Kroeger,et al. Pathogenesis and heterogeneity of ovarian cancer , 2016, Current opinion in obstetrics & gynecology.
[26] S. Narod,et al. Can advanced-stage ovarian cancer be cured? , 2016, Nature Reviews Clinical Oncology.
[27] A. Letai,et al. Mitochondria-Judges and Executioners of Cell Death Sentences. , 2016, Molecular cell.
[28] David John Adams,et al. Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[29] Carmela Fimognari,et al. Broad targeting of resistance to apoptosis in cancer , 2015, Seminars in cancer biology.
[30] T. Mak,et al. Caspase functions in cell death and disease. , 2015, Cold Spring Harbor perspectives in biology.
[31] Qiang Z Yu,et al. Apoptosis, autophagy, necroptosis, and cancer metastasis , 2015, Molecular Cancer.
[32] Maria Markaki,et al. Crosstalk between apoptosis, necrosis and autophagy. , 2013, Biochimica et biophysica acta.
[33] David R McIlwain,et al. Caspase functions in cell death and disease. , 2013, Cold Spring Harbor perspectives in biology.
[34] V. Préat,et al. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. , 2012, Molecular pharmaceutics.
[35] Fan Wang,et al. Evaluation of 111In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability , 2011, Theranostics.
[36] G. V. Chaitanya,et al. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration , 2010, Cell Communication and Signaling.
[37] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[38] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[39] Horst Kessler,et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.